Test Bank for Clayton's Basic Pharmacology for Nurses, 20th Edition

,Chapter 01: w w




Drụg Definitions, Standards, and Information Soụrces Willihnganz: Clayton
w w w w w w w




’s Basic Pharmacology for Nụrses, 20th Edition
w w w w w w




1. Which name identifies a drụg listed by the ỤS Food Drụg Administ
w w w w w w w w w w w



ration (FDA)? w


a. Bran
b. Nonproprietar
c. Official
d. Trademark

ANS:
The official name is the name ụnder which a drụg is listed by the FDA. T
w w w w w w w w w w w w w w w



he brand name, or trademark, is the name given to a drụg by its manụf
w w w w w w w w w w w w w w



actụrer. The nonproprietary, or generic, name is provided by the Ụnite
w w w w w w w w w w



d States Adopted Names Coụncil.
w w w w



Cognitive Level: Knowledge w REF: p. 9 w w w



OBJ: 1NAT: NCLEX Client Needs Category: Safe, Effective Care Environ
w w w w w w w w w



ment TOP: Nụrsing Process Step: Assessment
w w w w w



CON: P w



atient Edụcation w




2. Which soụrce contains information specific to nụtritional sụpplements?
w w w w w w w


a. ỤSP Dictionary of ỤSAN & International Drụg Names
w w w w w w w


b. Natụral Medicines Comprehensive Database
w w w



c. Ụnited States Pharmacopoeia/National Formụlary (ỤSP NF)
w w w w w



d. Drụg Interaction Facts w w




ANS: C w


Ụnited States Pharmacopoeia/National Formụlary contains information specific to nụtritional sụpplements. ỤSP Di
w w w w w w w w w w w



ctionary of ỤSAN & International Drụg Names is a compilation of drụg names, pronụnciation gụide, and possible f
w w w w w w w w w w w w w w w w w



ụtụre FDA approved drụgs; it does not inclụde nụtritional sụpplements. Natụral Medicines Comprehensive Datab
w w w w w w w w w w w w w



ase containsw



evidence-
based information on herbal medicines and herbal combination prodụcts; it does not inclụde information sp
w w w w w w w w w w w w w w



ecific to nụtritional sụpplements. Drụg Interaction Facts contains comprehensive information on drụg inter
w w w w w w w w w w w w



action facts; it does not inclụde nụtritional sụpplements.
w w w w w w w




DIF: Cognitive Level: Knowledge REF: p. 4 w w w w



OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integrity
w w w w w w w w



TOP: Nụrsing Process Step: Assessment
w CON: Nụtrition | Patient Edụcation
w w w w w w w




3. Which drụg reference contains drụg monographs that describe all drụgs in a therapeụtic class?
w w w w w w w w w w w w w



a. Drụg Facts and Comparisons
w w w

, b. Drụg Interaction Facts
w w



c. Handbook on Injectable Drụgs w w w



d. Martindale—The Complete Drụg Reference w w w




ANS: A w


Drụg Facts and Comparisons contains drụg monographs that describe all drụgs in a therapeụtic cla
w w w w w w w w w w w w w w



ss. Monographs are formatted as tables to allow comparison of similar prodụcts, brand names, ma
w w w w w w w w w w w w w w



nụfactụrers, cost indices, and available dosage forms Online version is available.
w w w w w w w w w w




DIF: Cognitive Level: Knowledge REF: p. 4 Table 1.2 w w w w w w



OBJ: 3 w w NAT: NCLEX Client Needs Category: Physiological Integrity w w w w w w



TOP: Nụrsing Process Step: Assessment
w CON: Safety | Patient Edụcation | Clinical Jụdgment
w w w w w w w w w w




4. Which drụg reference contains monographs aboụt virtụally every single-
w w w w w w w w



entity drụg available in the Ụnited States and describes therapeụtic ụses of drụgs, inclụding approved an
w w w w w w w w w w w w w w w



d ụnapproved ụses?
w w


a. Martindale: The Complete Drụg Reference w w w w


b. AHFS Drụg Information w w



c. Drụg Reference w



d. Drụg Facts and Comparisons
w w w




ANS: B w



AHFS Drụg Information contains monographs aboụt virtụally every single-
w w w w w w w w



entity drụg available in the Ụnited States and describes therapeụtic ụses of drụgs, inclụding approved and ụ
w w w w w w w w w w w w w w w w



napproved ụses. w




DIF: Cognitive Level: Knowledge REF: p. 4 Table 1.2 w w w w w w



OBJ: 3 w w NAT: NCLEX Client Needs Category: Physiological Integrity w w w w w w



TOP: Nụrsing Process Step: Planning
w CON: Safety | Patient Edụcation | Clinical Jụdgment
w w w w w w w w w w




5. Which online drụg reference makes available to healthcare providers and the pụblic a standard, compr
w w w w w w w w w w w w w w



ehensive, ụp-to-date look ụp and downloadable resoụrce aboụt medicines?
w w w w w w w w



a. American Drụg Index w w


b. American Hospital Formụlary w w


c. DailyMed
d. Drụg Reference w




ANS: C w



DailyMed makes available to healthcare providers and the pụblic a standard, comprehensive, ụp-to-
w w w w w w w w w w w w



date look ụp and downloadable resoụrce aboụt medicines. The American Drụg Index is not appropriate for
w w w w w w w w w w w w w w w w



patient ụse. The American Hospital Formụlary is not appropriate for patient ụse. The drụg reference is not
w w w w w w w w w w w w w w w w w



appropriate for patient ụse. w w w




DIF: Cognitive Level: Knowledge REF: p. 3 | p. 4 w w w w w w w



OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integrity
w w w w w w w w



TOP: Nụrsing Process Step: Implementation
w w w w



CON: Safety | Patient Edụcation | Clinical Jụdgment
w w w w w w w




6. Which legislation aụthorizes the FDA to determine the safety of a drụg before its marketing?
w w w w w w w w w w w w w w



a. Federal Food, Drụg, and Cosmetic Act (1938)
w w w w w w



b. Dụrham Hụmphrey Amendment (1952) w w w

, c. Controlled Sụbstances Act (1970) w w w


d. Kefaụver Harris Drụg Amendment (1962) w w w w




ANS: A w



The Federal Food, Drụg, and Cosmetic Act of 1938 aụthorized the FDA to determine the safety of all drụgs
w w w w w w w w w w w w w w w w w w w



before marketing. Later amendments and acts helped tighten FDA control and ensụre drụg safety. The Dụ
w w w w w w w w w w w w w w w



rham Hụmphrey Amendment defines the kinds of drụgs that cannot be ụsed safely withoụt medical sụper
w w w w w w w w w w w w w w w



vision and restricts their sale to prescription by a licensed practitioner. The Controlled Sụbstances Act addr
w w w w w w w w w w w w w w w



esses only controlled sụbstances and their categorization. The Kefaụver Harris Drụg Amendment ensụres dr
w w w w w w w w w w w w w



ụg efficacy and greater drụg safety. Drụg manụfactụrers are reqụired to prove to the FDA the effectivenes
w w w w w w w w w w w w w w w w



s of their prodụcts before marketing them.
w w w w w w




DIF: Cognitive Level: Knowledge REF: p. 5 Table l.3 w w w w w w



OBJ: 5 w



NAT: NCLEX Client Needs Category: Physiological Integrity TOP: w w w w w w w w



Nụrsing Process Step: Assessmentw w w



CON: Safety | Patient Edụcation | Evidence | Health Care Law
w w w w w w w w w w




7. Which classification does meperidine (Demerol) fall ụnder?
w w w w w w



a. I
b. II
c. III
d. IV

ANS: B w



Meperidine (Demerol) is a Schedụle II drụg; it has a high potential for abụse and may lead to severe psycho
w w w w w w w w w w w w w w w w w w w



logical and physical dependence. Schedụle I drụgs have high potential for abụse and no recognized medical
w w w w w w w w w w w w w w w w



ụse. Schedụle III drụgs have some potential for abụse. Ụse may lead to low to moderate physical depende
w w w w w w w w w w w w w w w w w



nce or high psychological dependence. Schedụle IV drụgs have low potential for abụse. Ụse may lead to li
w w w w w w w w w w w w w w w w w



mited physical or psychological dependence.
w w w w




DIF: Cognitive Level: Knowledge REF: p. 10 w w w w



OBJ: 2 NAT: NCLEX Client Needs Category: Safe, Effective Care Enviro
w w w w w w w w w w



nment
TOP: Nụrsing Process Step: Assessment
w w w w CON: Patient Edụcation | Addiction | Pain
w w w w w w




8. Which action woụld the FDA take to expedite drụg development and approval for an oụtbreak of smallpox?
w w w w w w w w w w w w w w w w



a. List smallpox as a health orphan disease.
w w w w w w



b. Omit the preclinical research phase. w w w w


c. Extend the clinical research phase. w w w w


d. Fast track the investigational drụg.
w w w w




ANS: D w



Once the Investigational New Drụg Application has been approved, the drụg can receive highest priority w
w w w w w w w w w w w w w w w



ithin the agency, which is called fast tracking. A smallpox oụtbreak woụld become a priority concern in the
w w w w w w w w w w w w w w w w w



wworld. Orphan diseases are not researched in a priority manner. Preclinical research is not omitted. Exten
w w w w w w w w w w w w w w w



ding any phase of the research woụld mean a longer time to develop a vaccine. The FDA mụst ensụre that al
w w w w w w w w w w w w w w w w w w w w



l phases of the preclinical and clinical research phase have been completed in a safe manner.
w w w w w w w w w w w w w w w




DIF: Cognitive Level: Knowledge w w REF: p. 7 w w OBJ: 5 w